BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33301607)

  • 1. Refitting the Model for End-Stage Liver Disease for the Eurotransplant Region.
    Goudsmit BFJ; Putter H; Tushuizen ME; Vogelaar S; Pirenne J; Alwayn IPJ; van Hoek B; Braat AE
    Hepatology; 2021 Jul; 74(1):351-363. PubMed ID: 33301607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revising model for end-stage liver disease from calendar-time cross-sections with correction for selection bias.
    de Ferrante HC; van Rosmalen M; Smeulders BML; Vogelaar S; Spieksma FCR
    BMC Med Res Methodol; 2024 Feb; 24(1):51. PubMed ID: 38419019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation.
    Leise MD; Kim WR; Kremers WK; Larson JJ; Benson JT; Therneau TM
    Gastroenterology; 2011 Jun; 140(7):1952-60. PubMed ID: 21334338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should All Status 1A Patients Be Prioritized Over High MELD Patients? Concept of Risk Stratification in Extremely Ill Liver Transplant Recipients.
    Safwan M; Nwagu U; Collins K; Abouljoud M; Nagai S
    Transplantation; 2019 Oct; 103(10):2121-2129. PubMed ID: 30747840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Center-related Bias in MELD Scores Within a Liver Transplant UNOS Region: A Call for Standardization.
    Verna EC; Connelly C; Dove LM; Adem P; Babic N; Corsetti J; Faix J; Hayden JA; Lifshitz M; Stotler B; Jin Z; Mohan S; Emond JC; Hod EA; Kratz A
    Transplantation; 2020 Jul; 104(7):1396-1402. PubMed ID: 31651793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era.
    Kim WR; Mannalithara A; Heimbach JK; Kamath PS; Asrani SK; Biggins SW; Wood NL; Gentry SE; Kwong AJ
    Gastroenterology; 2021 Dec; 161(6):1887-1895.e4. PubMed ID: 34481845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the Model for End-stage Liver Disease sodium (MELD-Na) score in the Eurotransplant region.
    Goudsmit BFJ; Putter H; Tushuizen ME; de Boer J; Vogelaar S; Alwayn IPJ; van Hoek B; Braat AE
    Am J Transplant; 2021 Jan; 21(1):229-240. PubMed ID: 32529758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wait-list mortality of young patients with Biliary atresia: Competing risk analysis of a eurotransplant registry-based cohort.
    van der Doef HPJ; van Rheenen PF; van Rosmalen M; Rogiers X; Verkade HJ;
    Liver Transpl; 2018 Jun; 24(6):810-819. PubMed ID: 29377411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.
    Somsouk M; Kornfield R; Vittinghoff E; Inadomi JM; Biggins SW
    Liver Transpl; 2011 Feb; 17(2):129-36. PubMed ID: 21280185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disparities in Eurotransplant liver transplantation wait-list outcome between patients with and without model for end-stage liver disease exceptions.
    Umgelter A; Hapfelmeier A; Kopp W; van Rosmalen M; Rogiers X; Guba M;
    Liver Transpl; 2017 Oct; 23(10):1256-1265. PubMed ID: 28650098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The decreasing predictive power of MELD in an era of changing etiology of liver disease.
    Godfrey EL; Malik TH; Lai JC; Mindikoglu AL; Galván NTN; Cotton RT; O'Mahony CA; Goss JA; Rana A
    Am J Transplant; 2019 Dec; 19(12):3299-3307. PubMed ID: 31394020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraregional model for end-stage liver disease score variation in liver transplantation: Disparity in our own backyard.
    Croome KP; Lee DD; Burns JM; Keaveny AP; Taner CB
    Liver Transpl; 2018 Apr; 24(4):488-496. PubMed ID: 29365357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Region 11 MELD Na exception prospective study.
    Fisher RA; Heuman DM; Harper AM; Behnke MK; Smith AD; Russo MW; Zacks S; McGillicuddy JW; Eason J; Porayko MK; Northup P; Marvin MR; Hundley J; Nair S
    Ann Hepatol; 2012; 11(1):62-7. PubMed ID: 22166562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.
    Gadiparthi C; Cholankeril G; Yoo ER; Hu M; Wong RJ; Ahmed A
    Dig Dis Sci; 2018 Jun; 63(6):1647-1653. PubMed ID: 29611079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality Risk Factors Among Patients With Cirrhosis and a Low Model for End-Stage Liver Disease Sodium Score (≤15): An Analysis of Liver Transplant Allocation Policy Using Aggregated Electronic Health Record Data.
    Atiemo K; Skaro A; Maddur H; Zhao L; Montag S; VanWagner L; Goel S; Kho A; Ho B; Kang R; Holl JL; Abecassis MM; Levitsky J; Ladner DP
    Am J Transplant; 2017 Sep; 17(9):2410-2419. PubMed ID: 28226199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
    Kwong AJ; Lai JC; Dodge JL; Roberts JP
    Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A model including standardized weight improved predicting waiting list mortality in adolescent liver transplant candidates: A US national study.
    Shaheen AA; Martin SR; Khorsheed S; Abraldes JG
    Liver Transpl; 2024 Mar; 30(3):269-276. PubMed ID: 37655999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MELDEQ : An alternative Model for End-Stage Liver Disease score for patients with hepatocellular carcinoma.
    Marvin MR; Ferguson N; Cannon RM; Jones CM; Brock GN
    Liver Transpl; 2015 May; 21(5):612-22. PubMed ID: 25694099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18.
    Biselli M; Dall'Agata M; Gramenzi A; Gitto S; Liberati C; Brodosi L; Ravaioli M; Gambato M; Montalti R; Pinna AD; Burra P; Gerunda GE; Cillo U; Andreone P; Bernardi M
    Liver Int; 2015 Jan; 35(1):184-91. PubMed ID: 24650058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease.
    Nadim MK; DiNorcia J; Ji L; Groshen S; Levitsky J; Sung RS; Kim WR; Andreoni K; Mulligan D; Genyk YS
    J Hepatol; 2017 Sep; 67(3):517-525. PubMed ID: 28483678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.